Urgent.News

What's breaking now, across thousands of outlets.

More in Finance & Markets

Samsung Biologics Raises $2.18 Billion to Expand Into Peptides

Samsung Biologics said its board approved a 3 trillion-won ($2.18 billion) capital increase on Aug. 28 to expand its presence in the global peptide drug market and increase production capacity.

  • Samsung Biologics raises $2.18 billion for peptide drug market expansion
  • Funds allocated for PolyPeptide Group acquisition and Songdo facility expansion
  • Plans to build six 180,000-liter capacity plants by 2032

More from Friday 28 August →